Vermersch P, et al. The EXPAND Study Results: Efficacy of Siponimod in Secondary Progressive Multiple Sclerosis. EAN 2017, O1217.
Adviespanel FDA positief over donanemab
jun 2024 | Dementie
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen
aug 2021 | Hoofdpijn